Carlos A. Zarate, M.D.

Affiliations: 
National Institute of Mental Health, Bethesda, MD, United States 
Area:
Depression, Ketamine
Google:
"Carlos Zarate"
Mean distance: 16.18 (cluster 29)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jones GH, Vecera CM, Ruiz AC, et al. (2024) A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder. The Journal of Clinical Psychiatry. 85
Quintanilla B, Zarate CA, Pillai A. (2024) Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects? Molecular Psychiatry
Evans JW, Graves MC, Nugent AC, et al. (2024) Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers. Scientific Reports. 14: 4538
Ballard ED, Nischal RP, Burton CR, et al. (2024) Clinical and electrophysiological correlates of hopelessness in the context of suicide risk. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 80: 38-45
Fountoulakis KN, Tohen M, Zarate CA. (2024) Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 81: 1-9
Alexander L, Hawkins PCT, Evans JW, et al. (2023) Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals. Translational Psychiatry. 13: 371
Lamontagne SJ, Gilbert JR, Zabala PK, et al. (2023) Clinical, behavioral, and electrophysiological profiles along a continuum of suicide risk: evidence from an implicit association task. Psychological Medicine. 1-10
Wang PR, Yavi M, Lee H, et al. (2023) An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. 43: 422-427
Punturieri C, Duncan WC, Greenstein D, et al. (2023) An exploration of actigraphy in the context of ketamine and treatment-resistant depression. International Journal of Methods in Psychiatric Research. e1984
Nikolin S, Rodgers A, Schwaab A, et al. (2023) Ketamine for the treatment of major depression: a systematic review and meta-analysis. Eclinicalmedicine. 62: 102127
See more...